Vystar Corp

      • Market Cap $531.33K
      • Debt $375.04K
      • Cash $27.77K
      • EV $878.60K
      • FCF $NaN

      Earnings

      loading chart...

      Sales & Net Margins

      loading chart...
      Earnings-$6.60M
      EBIT-$1.73M
      ROA-293%
      Equity-$8.25M
      Growth Stability1
      PE-0.08
      PB-0.06
      P/S3.58
      Price/Cash0.05
      Debt/Equity-0.05
      Net Margins-782%
      Gross Margins25%
      Op. Margins-1K%
      Sales Growth YoY-12%
      Sales Growth QoQ39%
      Sales CAGR29%
      Earnings Growth YoY-63%
      Earnings Growth QoQ20%
      Sales CAGR 5Y-53%
      Earnings CAGR 3Y-76%
      Sales CAGR 3Y-76%
      Market Cap$531.33K
      Revenue$148.27K
      Assets$589.46K
      Total Debt$375.04K
      Cash$27.77K
      Shares Outstanding13.28M
      EV878.6K
      Working Capital-7.29M
      Current Ratio0.06
      Gross Profit$37.72K
      Shares Growth 3y1%
      Equity Growth QoQ4%
      Equity Growth YoY139%

      Assets & ROA

      loading chart...

      Stockholders Equity & ROE

      loading chart...
      Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex, and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.

      SEC Filings

      Direct access to Vystar Corp (VYST) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

      • 2024
        • 10-Q Sep 30
        • 10-Q Jun 30
        • 10-Q Mar 31
      • 2023
        • 10-K Dec 31
        • 10-Q Sep 30
        • 10-Q Jun 30
        • 10-Q Mar 31
      • 2022
        • 10-K Dec 31
        • 10-Q Sep 30
        • 10-Q Jun 30
        • 10-Q Mar 31

      Sector Comparison

      How does Vystar Corp compare to its competitors?

      Not enough data to generate a comparison chart between Vystar Corp and its competitors. Please check back later.

      Peter Lynch's Chart

      This chart shows the current pricing of Vystar Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

      loading chart...

      Vystar Corp Discounted Cash Flow

      Fully customizable DCF calculator online for Vystar Corp.

      0
      012345678910TV
      fcf$0$0$0$0$0$0$0$0$0$0$0$0
      DCF$0$0$0$0$0$0$0$0$0$0$0
      Value$0

      Competitiveness and MOAT

      High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

      Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
      Net Margins-220%-327%-3K%-7K%-2K%-56%-40%-10%-4K%-2K%-782%
      ROA--251%-459%-368%-150%-22%-20%-26%-25%-216%-293%
      ROE-47%43%41%289%627%123%46%601%115%-

      Safety and Stability

      Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

      Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
      Debt over FCF--------2.37---
      Debt over Equity-0--0.3-0.54-0.27-1.44-0.83-1.2-0.47-0.05-0.05
      Growth Stability----------1

      Growth

      Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

      Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
      Revenue YoY growth--42%-89%-58%2K%4K%53%32%-100%351%-53%
      Earnings YoY growth--14%-1%-3%356%43%8%-68%61%92%-
      Equity YoY growth-3%8%1%-35%-34%448%-13%-88%906%-
      FCF YoY growth-3%-----25%---